Sign inJoin waitlistJoin the waitlist

Rashmi Murthy

Associate Professor, Breast Medical Oncology · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present

Hematology and Medical Oncology
University of Texas M D Anderson Cancer Center
2011–2014
Internal Medicine
Baylor College of Medicine
2008–2011
Doctor of Medicine
2004–2008

Research

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
New England Journal of Medicine · 2020 · First of 32 authors · 1,022 citations
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study
Journal of Clinical Oncology · 2020 · 657 citations
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
Journal of Clinical Oncology · 2020 · 452 citations

Vicente Valero
25 papers
Jennifer Litton
18 papers
SM
Stacy Moulder
17 papers
Gabriel Hortobagyi
15 papers
Elizabeth Mittendorf
12 papers
Banu Arun
11 papers
Carlos Barcenas
10 papers
Alastair Thompson
9 papers
Bora Lim
9 papers · 1 as a fellow
Clinton Yam
9 papers · 3 as a fellow
IK
Ian Krop
9 papers
Naoto Ueno
9 papers

Clinical trials

M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer
Principal investigator · Completed · Phase 1
M.D. Anderson Cancer Center
2018–2024
Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
Study chair · Terminated · Phase 2
University of Alabama at Birmingham
2019–2021